









BPH pathophysiology involves both glandular and stromal hyperplasia: glandular enlargement causes static obstructive effect through increased prostate volume, while stromal enlargement causes dynamic effect through increased parenchymal resistance.
The MRI classification of BPH into 8 types is clinically important because different types present with different symptom profiles and require different treatment strategies, making classification essential for optimal therapy selection.
Enlargement in BPH typically begins in periurethral glands during the fourth decade, then progresses to the transition zone which becomes the main site of involvement; TZ enlargement compresses peripheral zone in most cases.
MRI allows measurement of zonal and total prostate volume, determination of stromal-to-glandular component ratio, and detection of intravesicular protrusion—all factors that guide medical versus surgical intervention.
Approximately 50% of men with histologic BPH develop lower urinary tract symptoms including both storage (urgency, frequency) and voiding (hesitancy, weak stream) symptoms affecting quality of life.
Types 1 and 3 BPH (bilateral TZ enlargement, and combined TZ plus retrourethral enlargement) are the most common presentations, accounting for approximately 81% of cases in the literature.
Classify BPH type using systematic approach: assess transition zone enlargement (bilateral vs. absent) and retrourethral enlargement (present vs. absent) on sagittal images, then evaluate for pedunculated intravesicular protrusion and describe the stromal versus glandular composition and degree of urethral/trigonal displacement; document total prostate volume and specify which zones are involved to guide clinical management.